{"nctId":"NCT01389102","briefTitle":"Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms","startDateStruct":{"date":"2004-12"},"conditions":["Hot Flashes"],"count":454,"armGroups":[{"label":"Placebo transdermal three 90 μL sprays","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo transdermal three 90 μL sprays"]},{"label":"Placebo transdermal two 90 μL sprays","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo transdermal two 90 μL sprays"]},{"label":"Placebo transdermal one 90 μL spray","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo transdermal one 90 μL spray"]},{"label":"Estradiol transdermal three 90 μL sprays","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Estradiol transdermal three 90 μL sprays"]},{"label":"Estradiol transdermal two 90 μL sprays","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Estradiol transdermal spray, two 90 μL sprays"]},{"label":"Estradiol transdermal one 90 μL spray","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Estradiol transdermal one 90 μL spray"]}],"interventions":[{"name":"Estradiol transdermal one 90 μL spray","otherNames":[]},{"name":"Estradiol transdermal spray, two 90 μL sprays","otherNames":[]},{"name":"Estradiol transdermal three 90 μL sprays","otherNames":[]},{"name":"Placebo transdermal two 90 μL sprays","otherNames":[]},{"name":"Placebo transdermal three 90 μL sprays","otherNames":[]},{"name":"Placebo transdermal one 90 μL spray","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Post menopausal women,\n* Ages 35 or older,\n* Frequent moderate to severe hot flushes,\n* Qualifying general medical health\n\nExclusion Criteria:\n\n* Disqualifying gynecological disorders,\n* Disqualifying dermatological disorders,\n* Disqualifying concurrent conditions","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"35 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Change in the Number of Moderate to Severe Vasomotor Symptoms Per Day","description":"Patients completed a daily diary to record the number of mild, moderate and number of moderate or severe vasomotor symptoms \\[hot flushes and sweating\\] experienced each day.\n\nMild, moderate and severe hot flushes and sweating were defined as follows:\n\nMild = sensation of heat without sweating Moderate = sensation of heat with sweating, ability to continue activity Severe = sensation of heat with sweating, causing discontinuation of activity","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.32","spread":"6.30"},{"groupId":"OG001","value":"-6.19","spread":"5.77"},{"groupId":"OG002","value":"-4.76","spread":"5.84"},{"groupId":"OG003","value":"-8.44","spread":"4.50"},{"groupId":"OG004","value":"-8.66","spread":"6.65"},{"groupId":"OG005","value":"-8.10","spread":"4.02"}]}]}]},{"type":"PRIMARY","title":"Mean Change the Severity of Moderate to Severe Vasomotor Symptoms","description":"Patients completed a daily diary to record the number of mild, moderate and severe vasomotor symptoms experienced each day.\n\nMild, moderate and severe were defined as follows:\n\nMild = sensation of heat without sweating Moderate = sensation of heat with sweating, ability to continue activity Severe = sensation of heat with sweating, causing discontinuation of activity Severity of hot flushes was measured on a scale of none = 0, mild = 1, moderate = 2 and severe = 3.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.31","spread":"0.75"},{"groupId":"OG001","value":"-0.54","spread":"0.89"},{"groupId":"OG002","value":"-0.26","spread":"0.60"},{"groupId":"OG003","value":"-1.07","spread":"1.01"},{"groupId":"OG004","value":"-0.92","spread":"1.01"},{"groupId":"OG005","value":"-1.04","spread":"1.01"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":75},"commonTop":["Headache","Breast Tenderness","Nausea","Nasopharyngitis","Back pain"]}}}